Doyle Wealth Management Amgen Inc Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Doyle Wealth Management holds 9,869 shares of AMGN stock, worth $2.93 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

9,869

Previous 32,899 70.0%

Holding current value

$2.93 Million

Previous $8 Million 72.2%

% of portfolio

0.19%

Previous 0.65%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $5.17 Million - $5.83 Million	-23,030 Reduced 70.0%	9,869 $2.23 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $157,805 - $175,610	684 Added 2.12%	32,899 $8 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $175,635 - $194,298	-801 Reduced 2.43%	32,215 $7.79 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $2.08 Million - $2.38 Million	-10,441 Reduced 24.03%	33,016 $7.43 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $117,385 - $137,531	553 Added 1.29%	43,457 $9.24 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $390,078 - $432,763	1,670 Added 4.05%	42,904 $10.5 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $211,036 - $245,928	951 Added 2.36%	41,234 $10.3 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $1.99 Million - $2.37 Million	9,180 Added 29.51%	40,283 $9.26 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $6.72 Million - $7.47 Million	28,626 Added 1155.67%	31,103 $7.91 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $74,178 - $91,027	-375 Reduced 13.15%	2,477 $584,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $364 - $483	-2 Reduced 0.07%	2,852 $578,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $49,573 - $63,718	262 Added 10.11%	2,854 $688,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $72,952 - $87,411	-419 Reduced 13.92%	2,592 $502,000
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $500 - $586	3 Added 0.1%	3,011 $555,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $26,407 - $29,766	146 Added 5.1%	3,008 $517,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $126,307 - $147,441	708 Added 32.87%	2,862 $557,000
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $11,302 - $12,742	-61 Reduced 2.75%	2,154 $447,000
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $29,722 - $33,385	-179 Reduced 7.48%	2,215 $409,000
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $83,359 - $97,416	-492 Reduced 17.05%	2,394 $408,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $18,060 - $20,179	107 Added 3.85%	2,886 $502,000
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $464,898 - $530,789	2,779	2,779 $518,000

Others Institutions Holding AMGN

# of Institutions

3,108

Shares Held

404M

Call Options Held

7.35M

Put Options Held

7.05M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Amgen Inc Transaction History